Furosemide Injection, USP

DRUG2 trials

Sponsors

scPharmaceuticals, Inc., SQ Innovation, Inc.

Conditions

Heart Failure

Phase 1

Crossover Study to Compare the Pharmacokinetics and Bioavailability of a Novel Furosemide Regimen Administered Subcutaneously vs. the Same Dose Administered Intravenously in Subjects With Chronic Heart Failure

CompletedNCT04384653

SQ Innovation, Inc.Heart Failure

Start: 2020-10-17End: 2021-06-12Updated: 2026-06-15

Phase 2

Crossover Study to Compare the Pharmacokinetics and Bioavailability of a Novel Furosemide Regimen Administered Subcutaneously vs. the Same Dose Administered Intravenously in Subjects With Chronic Heart Failure

CompletedNCT02329834

scPharmaceuticals, Inc.Heart Failure

Start: 2015-04-30End: 2015-10-31Updated: 2022-12-02

Related Papers

An Adult Population Pharmacokinetic Model to Simulate Subcutaneous Administration of a Fixed Dose of Furosemide in Adolescents with Heart Failure and Volume Overload.

2025-05-13